Mary Frances Melville, PA-C

Mary Melville practices at Baptist Primary Care Inc in Jacksonville, Florida.

Mary Melville's NPI, 1962537605, was assigned on February 22, 2007. Mary Melville holds Florida license PA9101313.

Mary Melville's primary practice is Baptist Primary Care Inc, at 524 Skymarks Dr, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 376-3707.

Mary Melville's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Mary Melville is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Primary Care. Dmand AI also links Mary Melville to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mary Melville practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Mary Melville's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mary Melville is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mary Melville is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, anxiety, asthma, bronchitis, bursitis and chronic obstructive pulmonary disease (COPD) among the conditions Mary Melville treats.

CMS data shows 1,924 Medicare services from Mary Melville across 17 procedure codes in 2024, for 416 Medicare patients. Medicare paid $59,627 for them. Every service was in an office.

CMS counts 416 Medicare patients who saw Mary Melville in 2024. The largest group is 65 to 74, with 237 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mary Melville's median patient age at 63, with 80% women.

In 2024, Mary Melville wrote 2,832 Medicare Part D claims for 588 patients. 88% of them were for generic drugs. CMS names the drug for 2,356 of them, across 72 drugs with 11 or more claims each, at $62,969 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Mary Melville for performance year 2024, reported through an alternative payment model (APM). Mary Melville accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mary Melville as offering telehealth.

CMS Open Payments shows 115 general payments to Mary Melville from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $350.